These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6321850)
21. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition. Bauer JH Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722 [TBL] [Abstract][Full Text] [Related]
22. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
23. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory]. Durand D; Tran Van T; Ader JL; Suc JM Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547 [TBL] [Abstract][Full Text] [Related]
24. Antihypertensive effects of captopril and saralasin in essential and renal hypertension. Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597 [TBL] [Abstract][Full Text] [Related]
25. [Use of captopril in arterial hypertension with a stable and malignant course]. Lordkipanidze NL Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432 [No Abstract] [Full Text] [Related]
26. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic. Packer M Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750 [No Abstract] [Full Text] [Related]
34. Captopril and enalapril. Wilkin JK Ann Intern Med; 1983 Aug; 99(2):281. PubMed ID: 6309052 [No Abstract] [Full Text] [Related]
35. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Turini GA; Waeber B; Brunner HR Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835 [TBL] [Abstract][Full Text] [Related]
36. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension. Thind GS; Johnson A; Bhatnagar D; Henkel TW Am Heart J; 1985 Apr; 109(4):852-8. PubMed ID: 2984913 [TBL] [Abstract][Full Text] [Related]
37. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme. Weber MA; Drayer JI; Priest RT; Chen TC Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161 [TBL] [Abstract][Full Text] [Related]
38. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension. Reams GP; Bauer JH Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988 [TBL] [Abstract][Full Text] [Related]
39. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril. Atlas SA; Case DB; Yu ZY; Laragh JH Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554 [TBL] [Abstract][Full Text] [Related]
40. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension. Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]